- Home
- INAB vs IINN Comparison
INAB vs IINN Comparison
Compare INAB & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INAB
- IINN
- Stock Information
- Founded
- INAB 2016
- IINN 2018
- Country
- INAB United States
- IINN Israel
- Employees
- INAB N/A
- IINN N/A
- Industry
- INAB Biotechnology: Pharmaceutical Preparations
- IINN Medical/Dental Instruments
- Sector
- INAB Health Care
- IINN Health Care
- Exchange
- INAB Nasdaq
- IINN Nasdaq
- Market Cap
- INAB 14.5M
- IINN 13.7M
- IPO Year
- INAB 2021
- IINN 2021
- Fundamental
- Price
- INAB $4.17
- IINN $0.73
- Analyst Decision
- INAB Strong Buy
- IINN Strong Buy
- Analyst Count
- INAB 2
- IINN 1
- Target Price
- INAB $3.60
- IINN $2.00
- AVG Volume (30 Days)
- INAB 7.9M
- IINN 825.5K
- Earning Date
- INAB 05-07-2025
- IINN 06-13-2025
- Dividend Yield
- INAB N/A
- IINN N/A
- EPS Growth
- INAB N/A
- IINN N/A
- EPS
- INAB N/A
- IINN N/A
- Revenue
- INAB N/A
- IINN N/A
- Revenue This Year
- INAB N/A
- IINN N/A
- Revenue Next Year
- INAB N/A
- IINN N/A
- P/E Ratio
- INAB N/A
- IINN N/A
- Revenue Growth
- INAB N/A
- IINN N/A
- 52 Week Low
- INAB $0.10
- IINN $0.40
- 52 Week High
- INAB $4.17
- IINN $2.17
- Technical
- Relative Strength Index (RSI)
- INAB 98.72
- IINN 66.69
- Support Level
- INAB $0.10
- IINN $0.53
- Resistance Level
- INAB $0.19
- IINN $0.80
- Average True Range (ATR)
- INAB 0.11
- IINN 0.08
- MACD
- INAB 0.26
- IINN 0.03
- Stochastic Oscillator
- INAB 100.00
- IINN 81.36
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.